| pubmed-article:11329208 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11329208 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11329208 | lifeskim:mentions | umls-concept:C0332835 | lld:lifeskim |
| pubmed-article:11329208 | lifeskim:mentions | umls-concept:C0036186 | lld:lifeskim |
| pubmed-article:11329208 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
| pubmed-article:11329208 | lifeskim:mentions | umls-concept:C0038257 | lld:lifeskim |
| pubmed-article:11329208 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:11329208 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11329208 | pubmed:dateCreated | 2001-4-30 | lld:pubmed |
| pubmed-article:11329208 | pubmed:abstractText | The restenosis rate after stenting of lesions in aortocoronary venous bypass grafts still has to be considered unsatisfactorily high. We investigated a new stent design characterized by an expandable polytetrafluorethylene (PTFE) membrane in between two layers of struts. Five consecutive male patients (age 70 +/- 6 years) were followed prospectively who presented with at least two de novo lesions in different grafts 13 +/- 3 years after bypass surgery. A total of 11 lesions were treated located in grafts anastomosed to the circumflex (n = 3), to the LAD (n = 7), and to the right coronary artery (n = 1). Within the same procedure, every patient received membrane-covered stents (n = 6) and conventional stents (n = 5) in either of their lesions. All patients underwent successful interventions. The minimal luminal diameter increased from 1.0 +/- 0.5 to 2.9 +/- 0.6 mm in lesions treated by the membrane-covered stents and from 0.8 +/- 0.4 to 2.4 +/- 0.7 mm in the lesions treated by conventional stents. During follow-up, four out of five patients required angioplasty for in-stent restenosis of lesions covered by a conventional stent, whereas no patient underwent revascularization for a lesion treated by a membrane-covered device. The mean minimal luminal diameter of lesions covered by a conventional stent decreased by 42% to 1.4 +/- 0.6 mm; the mean minimal luminal diameter of the lesions treated by a stent graft declined by 9% to 2.8 +/- 0.6 mm (P < 0.05). This series of intraindividual comparisons suggests that membrane-covered stents may have the power to reduce in-stent restenosis in obstructed aortocoronary venous bypass grafts. | lld:pubmed |
| pubmed-article:11329208 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11329208 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11329208 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11329208 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11329208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11329208 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11329208 | pubmed:month | May | lld:pubmed |
| pubmed-article:11329208 | pubmed:issn | 1522-1946 | lld:pubmed |
| pubmed-article:11329208 | pubmed:author | pubmed-author:MeinertzTT | lld:pubmed |
| pubmed-article:11329208 | pubmed:author | pubmed-author:KösterRR | lld:pubmed |
| pubmed-article:11329208 | pubmed:author | pubmed-author:ReimersJJ | lld:pubmed |
| pubmed-article:11329208 | pubmed:author | pubmed-author:BaldusSS | lld:pubmed |
| pubmed-article:11329208 | pubmed:author | pubmed-author:HammC WCW | lld:pubmed |
| pubmed-article:11329208 | pubmed:author | pubmed-author:KählerJJ | lld:pubmed |
| pubmed-article:11329208 | pubmed:copyrightInfo | Copyright 2001 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:11329208 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11329208 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:11329208 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11329208 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11329208 | pubmed:pagination | 1-4 | lld:pubmed |
| pubmed-article:11329208 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:meshHeading | pubmed-meshheading:11329208... | lld:pubmed |
| pubmed-article:11329208 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11329208 | pubmed:articleTitle | Membrane-covered stents: a new treatment strategy for saphenous vein graft lesions. | lld:pubmed |
| pubmed-article:11329208 | pubmed:affiliation | Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany. | lld:pubmed |
| pubmed-article:11329208 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11329208 | lld:pubmed |
